Paper · 40323145
MRAS: Master Regulator Analysis of Alternative Splicing.
Zhou L and 9 others. Adv Sci (Weinh), 2025. Cited by 3 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. MRAS: Master Regulator Analysis of Alternative Splicing. Papers, record 40323145. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40323145
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alternative Splicing | Major topic |
| Neoplasms | Major topic |
| RNA Splicing Factors | Major topic |
| Computational Biology | Major topic |
| Humans |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2023YFF0725400 | National Key R&D Program of China | PubMed | ||
| 2022YFC2704202 | National Key R&D Program of China | PubMed | ||
| 32170565 | National Natural Science Foundation of China | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References73
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31,189,097 | The RNA-Binding Protein YBX3 Controls Amino Acid Levels by Regulating SLC mRNA Abundance. | Cell Rep | 2019 | https://conductscience.org/library/papers/31189097 | PubMed |
| 2 | 30,262,818 | Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy. | Nat Genet | 2018 | https://conductscience.org/library/papers/30262818 | PubMed |
| 3 | 22,264,731 | VEGF-induced vascular permeability is mediated by FAK. | Dev Cell | 2012 | https://conductscience.org/library/papers/22264731 | PubMed |
| 4 | 40,323,145 | MRAS: Master Regulator Analysis of Alternative Splicing. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40323145 | PubMed |
| 5 | 36,318,242 | ASCancer Atlas: a comprehensive knowledgebase of alternative splicing in human cancers. | Nucleic Acids Res | 2023 | https://conductscience.org/library/papers/36318242 | PubMed |
| 6 | 37,061,531 | Transcriptomics of Hirschsprung disease patient-derived enteric neural crest cells reveals a role for oxidative phosphorylation. | Nat Commun | 2023 | https://conductscience.org/library/papers/37061531 | PubMed |
| 7 | 32,728,246 | A large-scale binding and functional map of human RNA-binding proteins. | Nature | 2020 | https://conductscience.org/library/papers/32728246 | PubMed |
| 8 | 28,972,001 | Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis. | Circulation | 2017 | https://conductscience.org/library/papers/28972001 | PubMed |
| 9 | 33,476,558 | Splicing Control of Pontocerebellar Development. | Neuron | 2021 | https://conductscience.org/library/papers/33476558 | PubMed |
| 10 | 24,227,677 | featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. | Bioinformatics | 2014 | https://conductscience.org/library/papers/24227677 | PubMed |
1 to 10 of 73
See all 73 referencesCited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,919,159 | RBFOX3 is associated with neuronal-like phenotypic transition in recurrent glioblastoma. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42919159 | PubMed |
| 42,864,337 | RAISE quantifies RNA binding protein activity via transcriptomic profiling. | Nat Commun | 2026 | https://conductscience.org/library/papers/42864337 | PubMed |
| 41,584,352 | Unraveling the FGFR-RNA splicing axis: Mechanisms, oncogenic crosstalks and innovations for therapeutic purpose. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/41584352 | PubMed |
| 41,399,527 | Alternative Splicing: Molecular Mechanisms, Biological Functions, Diseases, and Potential Therapeutic Targets. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/41399527 | PubMed |
| 40,323,145 | MRAS: Master Regulator Analysis of Alternative Splicing. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40323145 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40323145
GET https://conductscience.org/api/papers/v1/40323145/references?page=2